Skip to main content
. 2020 Jul 28;7(4):261–269. doi: 10.1007/s40801-020-00207-6

Table 4.

Kaplan–Meier estimates for overall survival, stratified by number of ALK inhibitors

Overall population 1 ALK inhibitor 2 ALK inhibitors 3 ALK inhibitors
N = 410 N = 233 N = 144 N = 31
Median OS (95% CI) 27.6 (23.8, 36.1) 15.1 (10.5, 22.5) 42.4 (38.5, 60.3) 56.0 (31.0, 72.0)

ALK anaplastic lymphoma kinase, CI confidence interval, OS overall survival